[Treatment with thymogen and myelopid of patients with bronchial asthma].
Zoloedov. V I VI; Zemskov. A M AM; Stupnitskiĭ. A A AA; Goriainova. T A TA
Key Findings
- Alpha‑tocopherol acetate and nicotinamide lowered lipid‑peroxidation products in red‑cell membranes
- Antioxidant enzymes improved when these compounds were added to insulin therapy
- Authors propose early antioxidant treatment to protect beta‑cells and blood vessels
Practical Outcomes
- There’s no actionable information on thymogen dosing or use. The only takeaway is that antioxidants may benefit early type 1 diabetes, which is unrelated to the peptide focus of this community.
Summary
The abstract discusses vitamin E and nicotinamide helping early‑stage type 1 diabetes patients, not thymogen or asthma, so it offers no practical guidance for biohackers interested in the peptide.
Abstract
The authors studied the effect of alpha-tocopherol acetate and nicotinamide on lipid peroxidation and antioxidant enzyme defense (AED) in red cell membranes of 61 patients with new-onset insulin-dependent diabetes mellitus. Lipid peroxidation products were found in excessive quantities, whereas enzymes of the cell antioxidant defense were on the decrease. Combination of tocopherol with nicotinamide as adjuvants to conventional insulin therapy promoted normalization of lipid peroxidation and AED, improving beta-cell function. It is believed justified to introduce antioxidant treatment early in the disease onset to prevent toxic damage to beta-cells and vascular endothelium induced by lipid peroxidation products.
Study Information
pubmed
1995